Abrahamov, A. & Mechoulam, R. (1995) An efficient new cannabinoid anti-emetic in pediatric oncology. Life Sciences, 56, 2097–2102.
Beal, J. E., Olson, R., Laubenstein, L., et al (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain & Symptom Management, 10, 89–97.
Carlini, E. A. & Cunha, J. M. (1981) Hypnotic and antiepileptic effects of cannabidiol. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 417S–427S.
Chan, H. S., Correia, J. A. & MacLeod, S. M. (1987) Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Pediatrics, 79, 946–952.
Chang, A. E., Shiling, D. J., Stillman, R. C., et al (1979) Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Annals of Internal Medicine, 91, 819–824.
Chesher, G. B. & Jackson, D. M. (1985) The quasimorphine withdrawal syndrome: effect of cannabinol, cannabidiol and THC. Pharmacology, Biochemistry and Behaviour, 23, 13–15.
Clifford, D. B. (1983) Tetrahydrocannabinol for tremor in multiple sclerosis. Annals of Neurology, 13, 669–671.
Consroe, P. F., Wood, G. C. & Buchsbaum, H. (1975) Anticonvulsant nature of marihuana smoking. Journal of the American Medical Association, 234, 306–307.
Consroe, P. F., Laguna, J., Allender, J., et al (1991) Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacology, Biochemistry and Behavior, 40, 701–708.
Consroe, P. F., Musty, R., Rein, J., et al (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. European Neurology, 38, 44–48.
Cunha, J. M., Carlini, E. A., Pereira, A. E., et al (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 21, 175–185.
Dalzell, A. H., Bartlett, H. & Lilleyman, J. S. (1986) Nabilone: an alternative antiemetic for cancer chemotherapy. Annals of Diseases of Childhood, 61, 502–505.
Doblin, R. E. & Kleiman, M. A. R. (1991) Marijuana as anti-emetic medicine: a survey of oncologists' experiences and attitudes. Journal of Clinical Oncology, 9, 1314–1319.
Einhorn, L. H., Nagy, C., Furnas, B., et al (1981) Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 64S–69S.
Fabre, L. F. & McLendon, D. (1981) The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 377S–382S.
Foltin, R. W., Brady, J. V. & Fischman, M. W. (1986) Behavioral analysis of marijuana effects on food intake in humans. Pharmacology Biochemistry and Behavior, 25, 577–582.
Formukong, E. A., Evans, A. T. & Evans, F. J. (1989) The medicinal use of cannabis and its constituents. Phytotherapy Research, 3, 219–231.
Greenberg, H. S., Werness, S. A. S., Pugh, J. E., et al (1994) Short term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clinical Pharmacology and Therapeutics, 55, 324–328.
Grinspoon, L. & Bakalar, J. B. (1993) Marihuana, The Forbidden Medicine.
New Haven: Yale University Press.
Gross, H., Ebert, M. H., Faden, V. B., et al (1983) A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. Journal of Clinical Psychopharmacology, 3, 165–171.
Hall, W., Solowij, N. & Lemon, J. (eds) (1994) The Health and Psychological Consequences of Cannabis
. Canberra: Australian Government Publishing Service.
Harris, L. S., Munson, A. E. & Carchman, R. A. (1976) Antitumor properties of cannabinoids. In The Pharmacology of Marihuana, Vol. 2 (eds Braude, M. C. & Szara, S.), pp. 749–761. New York: Raven Press.
Hepler, R. S., Frank, I. M. & Petrus, R. (1976) The ocular effects of marihuana smoking. In The Pharmacology of Marihuana (eds Braude, M. C. & Szara, S.). New York: Raven Press.
Holdcroft, A., Smith, M., Jacklin, A., et al (1997) Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia, 52, 483–488.
Hollister, L. E. (1971) Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine. Clinical Pharmacology and Therapeutics, 12, 44–49.
House of Lords Select Committee on Science and Technology (1988) Cannabis: The Scientific and Medical Evidence (HL Paper 151). London: HMSO.
Ilaria, R. L., Thornby, J. I. & Fann, W. E. (1981) Nabilone, a cannabinol derivative, in the treatment of anxiety neuroses. Current Therapeutic Research, 29, 943–949.
Institute of Medicine (1999) Cannabinoids and animal physiology. In Marijuana and Medicine: Assessing the Science Base (eds Joy, J. E., Watson, S. J. & Benson, J. A.), pp. 2. 1–2.47. Washington, DC: National Academy Press.
Jain, A. K., Ryan, J. R., McMahon, F. G., et al (1981) Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 320S–326S.
Jones, R. T., Benowitz, N. L. & Herning, R. I. (1981) Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 143S–152S.
Jones, S. E., Durant, J. R., Greco, F. A., et al (1982) A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting. Cancer Treatment Review, 9 (suppl. B), 45–48.
Kaslow, R. A., Blackwelder, W. C., Ostrow, D. G., et al (1989) No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-I-positive individuals. Journal of the American Medical Association, 261, 3424–3429.
Keeler, M. H. & Reifler, C. B. (1967) Grand mal convulsions subsequent to marihuana use. Diseases of the Nervous System, 18, 474–475.
Lane, M., Vogel, C. L. & Ferguson, J. (1991) Dronabinol and prochlorperazine in combination are better than either agent alone for treatment of chemotherapy-induced nausea and vomiting. Proceedings of the American Society of Clinical Oncologists, 8, 326.
Levitt, M. (1986) Cannabinoids as antiemetics in cancer chemotherapy. In Cannabinoids as Therapeutic Agents (ed. Mechoulam, R.). Boca Raton, FA: CRC Press.
Maurer, M., Henn, V., Dittrich, A., et al (1990) Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. European Archives of Psychiatry and Clinical Neuroscience, 240, 1–4.
Mechoulam, R. (1986) The pharmacohistory of Cannabis sativa.
In Cannabinoids as Therapeutic Agents (ed. Mechoulam, R.), pp. 1–19. Boca Raton, FL: CRC Press.
Meek, C. (1994) Doctors want cannabis prescriptions allowed. BMA News Review, , p. 15.
Merritt, J. C., Crawford, W. J., Alexander, P. C., et al (1980) Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology, 87, 222–228.
Merritt, J. C., Olsen, J. L., Armstrong, J. R., et al (1981) Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas. Journal of Pharmacy and Pharmacology, 33, 40–41.
Niederle, N., Shütte, J. & Schmidt, C. G. (1986) Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy. Klinische Wochenschrift, 64, 362–365.
Niiranen, A. & Mattson, K. (1985) A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. American Journal of Clinical Oncology, 8, 336–340.
Noyes, R. Jr, Brunk, S. F., Baram, D. A., et al (1975a) Analgesic effect of delta-9-tetrahydrocannabinol. Journal of Clinical Pharmacology, 15, 139–143.
Noyes, R. Jr, Avery, D. A. H., et al (1975b) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clinical Pharmacology and Therapeutics, 18, 84–89.
Orr, L. E. & McKernan, J. G. (1981) Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 76S–80S.
Penta, J. S., Poster, D. S., Bruno, S., et al (1981) Clinical trials with anti-emetic agents in cancer patients receiving chemotherapy. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 11S–22S.
Perez-Reyes, M., Wagner, D., Wall, M. E., et al (1976) Intravenous administration of cannabinoids and intraocular pressure. In The Pharmacology of Marihuana (eds Braude, M. C. & Szara, S.), pp. 829–832. New York: Raven Press.
Pertwee, R. G. (1995) Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: an overview. In Cannabinoid Receptors (ed. Pertwee, R.), pp. 1–34. Harcourt Brace.
Petro, D. J. & Ellenberger, C. (1981) Treatment of human spasticity with delta-9-tetrahydrocannabinol. Journal of Clinical Pharmacology, 21 (suppl. 8–9), 413S–416S.
Plasse, T. F., Gorter, R. W., Krasnow, S. H., et al (1991) Recent clinical experience with dronabinol. Pharmacology, Biochemistry & Behaviour, 40, 695–700.
Pomeroy, M., Fennelly, J. J. & Towers, M. (1986) Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. Cancer Chemotherapy and Pharmacology, 17, 285–288.
Regelson, W., Butler, J. R., Schulz, J., et al (1976) Delta-9-THC as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In The Pharmacology of Marihuana (eds Braude, M. C. & Szara, S.), pp. 763–775. New York: Raven Press.
Reynolds, J. R. (1890) Therapeutic uses and toxic effects of cannabis indica. Lancet, i, 637–638.
Sallan, S. E., Zinberg, N. E. & Frei, E. 3rd (1975) Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. New England Journal of Medicine, 293, 795–797.
Tashkin, D. P., Reiss, S., Shapiro, B. J., et al (1977) Bronchial effects of aerosolized delta-9-THC in healthy and asthmatic subjects. American Review of Respiratory Disease, 115, 57–65.
Ungerleider, J. T., Andrysiak, T., Fairbanks, L., et al (1982) Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. Cancer, 50, 636–645.
Ungerleider, J. T., Andrysiak, T., Fairbanks, L., et al (1987) Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Advances in Alcoholism and Substance Abuse, 7, 39–50.